Prioritizing Pneumococcal Vaccine Introduction in the Developing World: the Indian Experience
Journal Title: Indian Journal of Communicable Diseases - Year 2017, Vol 3, Issue 2
Abstract
Pneumococcal diseases in ‘under 5 populations’ are responsible for millions of deaths annually in the developing world. Effective vaccination against pneumococcal diseases is available using vaccines but their high cost has inhibited their adoption by governments in low and middleincome countries. Resistance to adoption of these vaccines also stems from the lack of population based data pertaining to disease burden and serotype prevalence which preclude the possibility of accurate costeffective analysis and longterm impact of the vaccines in improving the health of susceptible populations. In India, the pneumococcal vaccine is set to be introduced in a phased manner in its Universal Immunization Program. The Indian experience shows that the vaccine can be adopted using justifications based upon disease burden estimates through mathematical modeling and serotype prevalence from hospital based studies especially when keeping the overarching ethical principle of protecting the lives of thousands of children in mind who cannot wait for theavailability of high quality evidence proving cost effectiveness of the vaccine. However, the replicability of such behaviour by comparatively poorer nations may be difficult which renders it necessary to correctly monitor and evaluate the impact of pneumococcal vaccine introduction in Indian populations in order to provide a roadmap for expansion of pneumococcal vaccines in other resource constrained settings of the developing world.
Authors and Affiliations
Suneela Garg
Keywords
Related Articles
- EP ID EP452006
- DOI 10.21088/ijcd.2395.6631.3217.5
- Views 100
- Downloads 0
Study of Immunodeftcieny Degree (CD 4 count) as a Predictor of Pulmonary Tuberculosis at a HIV Sentinel Surveillance Center, Ahmednagar
Diagnosing tuberculosis in Human Immunodeficiency Virus (HIV) infected person is a major public health challenge. An integral component of the World Health Organization (WHO) strategy for reducing the burden of HIV relat...
A Deterministic Model to Estimate the Cost Impact of Different Varicella Vaccination Strategies in a Tropical Setting with a Diverse Workforce
Background: Objectives of this study were 1. To review the impact of the Institutional Chickenpox Prevention Program (ICPP) at National University Hospital (NUH), Singapore from Jan 2010 – Jun 2014; 2. To compare the cos...
International Health Regulations: Is India Prepared after 10 Years of Implementation?
The International Health Regulations (IHR) is an international legal instrument applicable to all WHO member countries and came into force in 2007. The objective of the IHR is to prevent international spread of disease b...
Need to Vaccinate (HBV) and Train Medical Students Against Hazards of Hepatitis B: A Study Conducted among Final Year Medical Students
Not Available
Molluscum Contagiosum
Molluscum Contagiosum (MC) is a very common viral infection of skin caused by a double stranded DNA Pox virus affecting both children’s and adults. MC is primarily affects children’s of 15 years, occasionally it affects...